Dr. Lew Lim is the Founder and CEO of Vielight Inc., a company engaged in the research, development, and manufacturing of photobiomodulation (PBM) devices aimed at improving brain function and neurological health. He has played a key role in shaping Vielight’s research and engineering efforts, contributing to advancements in PBM applications. He also holds a significant portfolio of patents in the PBM field.

Dr. Lim actively publishes research and presents at conferences, sharing insights into PBM mechanisms and applications. Vielight collaborates with about 100 researchers worldwide, exploring PBM’s potential in traumatic brain injury (TBI), Alzheimer’s disease, cognitive function, and other neurological areas. These collaborations have led to novel findings in both clinical outcomes and cellular mechanisms, employing methodologies such as cell culture assays, MRI and EEG techniques, computational neuroscience, and artificial intelligence.

His academic background spans multiple disciplines, with degrees and credentials in neuroscience, engineering, natural medicine, accountancy, and business from institutions including the University of California, Berkeley, Sheffield University, Quantum University, and Duke University. His contributions to PBM research and innovation have been recognized with Canadian awards for scientific and technological advancements.